| scholarly article | Q13442814 |
| P50 | author | Andreas Leithner | Q33298184 |
| Bernadette Liegl-Atzwanger | Q33303657 | ||
| P2093 | author name string | Stefan Sauer | |
| Beate Rinner | |||
| Birgit Lohberger | |||
| Nicole Stuendl | |||
| Karl Kashofer | |||
| P2860 | cites work | A comprehensive functional analysis of PTEN mutations: implications in tumor- and autism-related syndromes | Q24320313 |
| P-TEN, the tumor suppressor from human chromosome 10q23, is a dual-specificity phosphatase | Q24322705 | ||
| Intratumor heterogeneity: evolution through space and time | Q24598678 | ||
| Tumour heterogeneity and the evolution of polyclonal drug resistance | Q26866803 | ||
| Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing | Q27860948 | ||
| PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer | Q27860985 | ||
| p53, the cellular gatekeeper for growth and division | Q27860990 | ||
| KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs) | Q28281017 | ||
| Multiple statistical analysis techniques corroborate intratumor heterogeneity in imaging mass spectrometry datasets of myxofibrosarcoma | Q28477284 | ||
| PTEN nuclear localization is regulated by oxidative stress and mediates p53-dependent tumor suppression | Q28505099 | ||
| Regulation of PTEN transcription by p53 | Q28646911 | ||
| VEGF receptor-2 variants are associated with susceptibility to stroke and recurrence. | Q54739399 | ||
| Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression | Q74052403 | ||
| Polymorphisms of KDR gene are associated with coronary heart disease | Q80813827 | ||
| ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data | Q29547161 | ||
| Circos: an information aesthetic for comparative genomics | Q29547653 | ||
| A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3 | Q29614852 | ||
| The causes and consequences of genetic heterogeneity in cancer evolution | Q29615848 | ||
| Cancer drug resistance: an evolving paradigm | Q29616694 | ||
| Tumour heterogeneity and cancer cell plasticity | Q29617990 | ||
| Intra-tumour heterogeneity: a looking glass for cancer? | Q29620149 | ||
| Mutational analysis of p53 and PTEN in soft tissue sarcoma | Q30408964 | ||
| Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer Data Base Report | Q31108344 | ||
| Imaging mass spectrometry of myxoid sarcomas identifies proteins and lipids specific to tumour type and grade, and reveals biochemical intratumour heterogeneity | Q33691890 | ||
| Correcting for cancer genome size and tumour cell content enables better estimation of copy number alterations from next-generation sequence data | Q34062061 | ||
| Assembly of microarrays for genome-wide measurement of DNA copy number | Q34099918 | ||
| CDKN2A gene deletions and loss of p16 expression occur in osteosarcomas that lack RB alterations | Q35753196 | ||
| Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix | Q35832096 | ||
| Chromosome 17 abnormalities and TP53 mutations in adult soft tissue sarcomas. | Q35833993 | ||
| Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics. | Q36673354 | ||
| Inactivation of p53 and Pten promotes invasive bladder cancer | Q37141814 | ||
| Wild-type p53 and a p53 temperature-sensitive mutant suppress human soft tissue sarcoma by enhancing cell cycle control. | Q40845394 | ||
| The spectrum of vascular anomalies in patients with PTEN mutations: implications for diagnosis and management | Q43232449 | ||
| Next-generation sequencing for simultaneous determination of human papillomavirus load, subtype, and associated genomic copy number changes in tumors | Q43484346 | ||
| Chondrosarcoma in the United States (1973 to 2003): an analysis of 2890 cases from the SEER database | Q43840932 | ||
| FGFR3 mutations in prostate cancer: association with low-grade tumors | Q47984250 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | RTCA | Q114077291 |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | heterogeneity | Q928498 |
| myxofibrosarcoma | Q53907631 | ||
| P304 | page(s) | 44700 | |
| P577 | publication date | 2017-03-17 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Establishment of a novel cellular model for myxofibrosarcoma heterogeneity | |
| P478 | volume | 7 |
| Q58116691 | Characterization and Drug Sensitivity of a New High-Grade Myxofibrosarcoma Cell Line |
| Q64900609 | Establishment and genomic characterization of gingivobuccal carcinoma cell lines with smokeless tobacco associated genetic alterations and oncogenic PIK3CA mutation. |
| Q48292408 | Expanded molecular profiling of myxofibrosarcoma reveals potentially actionable targets |
| Q64110013 | Human melanoma brain metastases cell line MUG-Mel1, isolated clones and their detailed characterization |
| Q90448041 | Multiple primary malignant neoplasms: A case report and literature review |
Search more.